Morgan Stanley Highlights-----Pimavanserin, the new Viagra - question to Dr Ballard | ACAD Message Board Posts

ACADIA Pharmaceuticals Inc.

  ACAD website

  • To open or close the box of links at the top of your board, click the "hide/show" button to the right of your page, as shown here:


    To view a vertical list of all your board links on a separate page, click the "View Full List" link in parentheses.

    In the meantime, we will see what we can do to bring more attention to the "hide/show" button, such as making it bigger and/or adding color to it.

    Please continue sending constructive feedback via PM to Admin or email admin@investorvillage.com. We appreciate hearing from you!

ACAD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  15622 of 16931  at  9/12/2019 2:17:43 AM  by

Biotech2050

The following message was updated on 9/12/2019 2:18:55 AM.

 In response to msg 15621 by  Biotech2050
view thread

Re: Morgan Stanley Highlights-----Pimavanserin, the new Viagra - question to Dr Ballard

  
  
 
 In your pimavanserin trials have you noticed the improvement mentioned below on your #dementia trial patients or is this only applicable to #depression patients ? Appreciate your thoughts. (Quote from $ACAD CEO webcast at Morgan Stanley)
 
My comment to you guys: just imagine for a moment if Nuplazid improves not only psychosis but also improves sexual appetite for PDP & DRP pateints too!
 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 378
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






Financial Market Data provided by
.


Loading...